LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · IEX Real-Time Price · USD
+1.27 (1.61%)
May 22, 2024, 4:00 PM EDT - Market closed

LeMaitre Vascular Revenue

LeMaitre Vascular had revenue of $199.89M in the twelve months ending March 31, 2024, with 18.16% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $53.48M with 13.60% year-over-year growth. In the year 2023, LeMaitre Vascular had annual revenue of $193.48M with 19.69% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
1.80B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023193.48M31.83M19.69%
Dec 31, 2022161.65M7.23M4.68%
Dec 31, 2021154.42M25.06M19.37%
Dec 31, 2020129.37M12.13M10.35%
Dec 31, 2019117.23M11.66M11.05%
Dec 31, 2018105.57M4.70M4.66%
Dec 31, 2017100.87M11.72M13.14%
Dec 31, 201689.15M10.80M13.78%
Dec 31, 201578.35M7.26M10.20%
Dec 31, 201471.10M6.55M10.14%
Dec 31, 201364.55M7.81M13.77%
Dec 31, 201256.74M-950.00K-1.65%
Dec 31, 201157.69M1.63M2.90%
Dec 31, 201056.06M5.15M10.12%
Dec 31, 200950.91M2.19M4.49%
Dec 31, 200848.72M7.27M17.55%
Dec 31, 200741.45M6.82M19.69%
Dec 31, 200634.63M3.90M12.70%
Dec 31, 200530.73M4.54M17.35%
Dec 31, 200426.18M5.52M26.71%
Dec 31, 200320.66M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Addus HomeCare 1.09B
Veracyte 375.47M
Protagonist Therapeutics 314.95M
Fusion Pharmaceuticals 2.04M
Inhibrx 1.78M
Revenue Rankings